(VIANEWS) – RANA GRUBER (RANA.OL), YARA INTERNATIONAL (YAR.OL), FORFARMERS (FFARM.AS) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| RANA GRUBER (RANA.OL) | 12.28% | 2023-03-20 04:33:46 |
| YARA INTERNATIONAL (YAR.OL) | 6.73% | 2023-03-20 04:36:49 |
| FORFARMERS (FFARM.AS) | 6.25% | 2023-03-20 04:03:12 |
| CRCAM ALP.PROV.CCI (CRAP.PA) | 5.99% | 2023-03-20 04:47:17 |
| NEXTENSA (NEXTA.BR) | 5.78% | 2023-03-20 04:16:22 |
| SOGECLAIR (SOG.PA) | 4.41% | 2023-03-20 04:04:44 |
| SANOFI (SAN.PA) | 3.74% | 2023-03-20 04:03:37 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. RANA GRUBER (RANA.OL)
12.28% Foward Dividend Yield
RANA GRUBER’s last close was kr58.30, 14.52% under its 52-week high of kr68.20. Intraday change was -1.89%.
Rana Gruber AS engages in the mining, processing, and sale of iron ore concentrate. The company excavates, processes, and sells iron oxide in the form of hematite, magnetite, and iron oxide pigments. It also produces magnetite iron oxide concentrates. The company offers its products under the Colorana brands. It exports its products worldwide. Rana Gruber AS was founded in 1937 and is headquartered in Mo i Rana, Norway.
Earnings Per Share
As for profitability, RANA GRUBER has a trailing twelve months EPS of kr7.3.
PE Ratio
RANA GRUBER has a trailing twelve months price to earnings ratio of 7.83. Meaning, the purchaser of the share is investing kr7.83 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 68.94%.
Volatility
RANA GRUBER’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.57%, a negative 0.42%, and a positive 1.58%.
RANA GRUBER’s highest amplitude of average volatility was 1.82% (last week), 1.14% (last month), and 1.58% (last quarter).
Sales Growth
RANA GRUBER’s sales growth for the next quarter is 20.1%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, RANA GRUBER’s stock is considered to be overbought (>=80).
More news about RANA GRUBER.
2. YARA INTERNATIONAL (YAR.OL)
6.73% Foward Dividend Yield
YARA INTERNATIONAL’s last close was kr444.30, 12.16% below its 52-week high of kr505.80. Intraday change was -1.19%.
Yara International ASA provides environmental and industrial solutions in Norway, European Union, Europe, Africa, Asia, North and Latin America, Australia, and New Zealand. The company offers nitrogen-based fertilizers, including urea, urea ammonium nitrate, calcium ammonium nitrate, ammonium nitrate, and ammonium sulfate; compound fertilizers that contain plant nutrients, such as nitrogen, phosphorus, and potassium; and blended products, as well as foliar and fertigation solutions through micronutrients. It also offers farmer centric solutions; solutions for farming, such as crop monitoring, variable rate fertilization, N-Tester BT, and Driving Mode, a mobile app; N-Sensor, a tractor-mounted tool that allows growers to measure a crop's nitrogen requirement; CheckIT, a smartphone app using a library of crop photographs to give a simple and fast identification of nutrient deficiencies; TankmixIT, an app used to check for the physical compatibility when tank mixing; and Tankmix.com, an online service providing advice on the physical mixing characteristics of Yara's foliar products with agrochemicals. The company sells its products under YaraBela, YaraLiva, YaraMila, YaraRega, YaraTera, YaraVera, and YaraVita brands name. Yara International ASA was founded in 1905 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, YARA INTERNATIONAL has a trailing twelve months EPS of kr25.62.
PE Ratio
YARA INTERNATIONAL has a trailing twelve months price to earnings ratio of 17.13. Meaning, the purchaser of the share is investing kr17.13 for every norwegian krone of annual earnings.
More news about YARA INTERNATIONAL.
3. FORFARMERS (FFARM.AS)
6.25% Foward Dividend Yield
FORFARMERS’s last close was €3.20, 10.74% under its 52-week high of €3.59. Intraday change was -2.34%.
ForFarmers N.V. provides feed solutions for conventional and organic livestock farming in the Netherlands, Belgium, Germany, Poland, and the United Kingdom. It offers compound feed and blends, feed for young animals and specialties, raw materials and coproducts, seeds, and fertilizers. The company is involved in production and delivery of feed, as well as engaged in logistics services. ForFarmers N.V. was founded in 1896 and is headquartered in Lochem, the Netherlands.
Earnings Per Share
As for profitability, FORFARMERS has a trailing twelve months EPS of €0.148.
PE Ratio
FORFARMERS has a trailing twelve months price to earnings ratio of 21.11. Meaning, the purchaser of the share is investing €21.11 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.12%.
More news about FORFARMERS.
4. CRCAM ALP.PROV.CCI (CRAP.PA)
5.99% Foward Dividend Yield
CRCAM ALP.PROV.CCI’s last close was €65.90, 18.54% under its 52-week high of €80.90. Intraday change was -0.15%.
Caisse Régionale de Crédit Agricole Mutuel Alpes Provence Société coopérative provides banking products and services in France. The company offers bank accounts; cards; e-documents; savings products; pension and employee savings products; real estate and consumer credit loans; cash management, business creation finance, medium term credit, and leasing services. It also provides life, health, employee, professional vehicle, activity, car and two-wheeler, personal, home, leisure and daily, borrowers, and professional premises insurance products. In addition, the company offers agriculture banking products and services. The company serves individuals, associations, professionals, businesses, farmers, and communities. Caisse Régionale de Crédit Agricole Mutuel Alpes Provence Société cooperative was founded in 1885 and is based in Aix-en-Provence, France.
Earnings Per Share
As for profitability, CRCAM ALP.PROV.CCI has a trailing twelve months EPS of €14.99.
PE Ratio
CRCAM ALP.PROV.CCI has a trailing twelve months price to earnings ratio of 4.39. Meaning, the purchaser of the share is investing €4.39 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.04%.
Moving Average
CRCAM ALP.PROV.CCI’s worth is below its 50-day moving average of €70.29 and above its 200-day moving average of €65.69.
Volume
Today’s last reported volume for CRCAM ALP.PROV.CCI is 31 which is 87.02% below its average volume of 239.
More news about CRCAM ALP.PROV.CCI.
5. NEXTENSA (NEXTA.BR)
5.78% Foward Dividend Yield
NEXTENSA’s last close was €39.90, 45.27% below its 52-week high of €72.90. Intraday change was -4.39%.
Nextensa NV/SA is a mixed real estate investor and developer. The company's investment portfolio, which is spread over the Grand Duchy of Luxembourg (46%), Belgium (41%) and Austria (13%), had a total value on 30/09/2022 of approximately €1.35 billion. As a developer, Nextensa is mainly active in shaping large urban developments. At Tour & Taxis (development of more than 350,000 sqm) in Brussels, Nextensa is building a mixed real estate patrimony consisting of the revaluation of iconic buildings and new constructions. In Luxembourg (Cloche d'Or), it is working in partnership on a major urban extension of more than 400,000 sqm consisting of offices, retail and residential units. The company is listed on Euronext Brussels and has a market capitalisation of € 541.1 million (at 30/09/2022).
Earnings Per Share
As for profitability, NEXTENSA has a trailing twelve months EPS of €11.19.
PE Ratio
NEXTENSA has a trailing twelve months price to earnings ratio of 3.41. Meaning, the purchaser of the share is investing €3.41 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.69%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 137%, now sitting on 131.16M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NEXTENSA’s stock is considered to be overbought (>=80).
Volatility
NEXTENSA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.72%, a negative 1.19%, and a positive 1.78%.
NEXTENSA’s highest amplitude of average volatility was 4.47% (last week), 2.17% (last month), and 1.78% (last quarter).
More news about NEXTENSA.
6. SOGECLAIR (SOG.PA)
4.41% Foward Dividend Yield
SOGECLAIR’s last close was €20.40, 21.54% below its 52-week high of €26.00. Intraday change was 0.98%.
Sogeclair SA provides engineering and production services to the aeronautics, space, civil and military transport in France. It operates through three divisions: Aerospace, Vehicle, and Simulation. The Aerospace division engages in the provision of engineering services in aerostructures, cabins, systems, and manufacturing engineering and tooling services; and design and manufacture of complex structural thermoplastic products, additive manufacturing, and cockpit equipment, as well as cabin furniture and mechanism. The Vehicle division is involved in the design and production of special civilian and military vehicles, as well as terrestrial drones, multi-mission platforms, and adapting vehicles. The Simulation division engages in the design and supply of turnkey simulators; and development of software simulation platforms. Sogeclair SA was incorporated in 1986 and is headquartered in Blagnac, France.
Earnings Per Share
As for profitability, SOGECLAIR has a trailing twelve months EPS of €-4.84.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.11%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.3%, now sitting on 129.51M for the twelve trailing months.
More news about SOGECLAIR.
7. SANOFI (SAN.PA)
3.74% Foward Dividend Yield
SANOFI’s last close was €89.80, 15.81% below its 52-week high of €106.66. Intraday change was -0.78%.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €9.68.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 9.2. Meaning, the purchaser of the share is investing €9.2 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.77%.
Volatility
SANOFI’s last week, last month’s, and last quarter’s current intraday variation average was 0.50%, 0.03%, and 0.79%.
SANOFI’s highest amplitude of average volatility was 0.74% (last week), 0.64% (last month), and 0.79% (last quarter).
More news about SANOFI.
